Prosecution Insights
Last updated: November 20, 2026

Stephen Thomas Kapushoc, USPTO Patent Examiner

Listed by the USPTO as KAPUSHOC, STEPHEN THOMAS

Tech Center 1700 • Art Units: 1634 1682 1683 1699 1758

This examiner grants 47% of resolved cases

Analysis

KAPUSHOC, STEPHEN THOMAS has resolved 745 cases in tech center 1700 and art unit 1634. The allowance rate is 46.6%, while the interview lift is 53.7%. The interview measure exceeds the allowance result, making interview preparation a potentially important component of prosecution strategy. The median time to allowance is 1379 days, so applicants should plan around an extended examination process.

The recorded companies include Mcmaster University, Natera Inc., and Wisconsin Alumni Research Foundation. Listed firms are FOLEY & LARDNER LLP, WOLF GREENFIELD & SACKS, P.C., and AMPACC Law Group, PLLC. This substantial case record and recurring participant history can support focused preparation for applications in the relevant technology area.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

46.6%
Allow Rate
-18.4% vs TC avg
826
Total Applications
+53.7%
Interview Lift
1379
Avg Prosecution Days
Based on 745 resolved cases, 2023–2026

Rejection Statute Breakdown

23.3%
§101 Eligibility
11.3%
§102 Novelty
22.4%
§103 Obviousness
34.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18756518 ASSESSING GRAFT SUITABILITY FOR TRANSPLANTATION Non-Final OA Natera, Inc.
17926804 EPIGENETIC MODIFICATION OF SELECT GENES AS MARKERS OF HYPERSOMNOLENCE Final Rejection Wisconsin Alumni Research Foundation
18168955 METHODS OF DETERMINING COVID-19 MORTALITY RISK Non-Final OA WASHINGTON UNIVERSITY
17776822 METHODS OF SYNTHESIZING RNA MOLECULES Final Rejection BAYER HEALTHCARE LLC
18258485 IDENTIFICATION AND TREATMENT OF PATIENTS WITH EPILEPSY Final Rejection Jazz Pharmaceuticals Research UK Limited
18362013 SEQUENCE CONVERSION AND SIGNAL AMPLIFIER DNA HAVING ABASIC NUCLEIC ACIDS, AND DETECTION METHODS USING SAME Final Rejection ABBOTT LABORATORIES
18426589 GENE ANALYSIS METHOD AND KIT FOR GENE ANALYSIS Non-Final OA HITACHI, LTD.
18435731 NUCLEIC ACID SEQUENCE ANALYSIS Non-Final OA Arizona Board of Regents on behalf of Arizona State University
18332933 Hybridization Chain Reaction Methods for In Situ Molecular Detection Non-Final OA President and Fellows of Harvard College
17794269 AN EPIGENETIC CLOCK FOR GALLIFORMES Final Rejection EVONIK OPERATIONS GMBH
17435728 METHODS OF DETECTING AND TREATING VENETOCLAX-RESISTANT ACUTE MYELOID LEUKEMIA Final Rejection The Regents of the University of Colorado, A Body Corporate
18042167 BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS Final Rejection OTSUKA PHARMACEUTICAL CO., LTD.
19125204 LIBRARY PREPARATION AND ANALYTICAL METHODS FOR PRESERVING TOPOLOGICAL INFORMATION OF CELL-FREE DNA Non-Final OA Roche Sequencing Solutions, Inc.
18691868 APPARATUSES, SYSTEMS, AND METHODS FOR DETECTING BIOMARKERS ASSOCIATED WITH RISK OF PRESSURE INJURIES Non-Final OA CASE WESTERN RESERVE UNIVERSITY
17920652 METHOD FOR DETECTING SEVERITY OF PREMENSTRUAL SYNDROME Final Rejection KAO CORPORATION
18334221 TL1A THERAPY COMPOSITIONS AND METHODS OF TREATMENT THEREWITH Final Rejection CEDARS-SINAI MEDICAL CENTER
18270684 HIGH-SPATIAL-RESOLUTION EPIGENOMIC PROFILING Non-Final OA YALE UNIVERSITY
18698630 METHODS AND KITS FOR DIAGNOSING MUSCLE ATROPHY Non-Final OA CENTRE HOSPITALIER UNIVERSITAIRE DE CLERMONT-FERRAND
18267038 DIAGNOSTICS AND THERAPEUTICS FOR EBV IN MS AND OTHER AUTOIMMUNE DISEASES Non-Final OA THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
18681271 COMPOSITIONS AND METHODS FOR FAST MULTIPLEXED SCREENING AND MONITORING OF NPM1 MUTATIONS Non-Final OA The University of Hong Kong
16837476 STRATIFICATION OF RISK OF VIRUS ASSOCIATED CANCERS Non-Final OA GRAIL, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Stephen Thomas Kapushoc's allowance rate?

46.6% of resolved applications examined by Stephen Thomas Kapushoc were allowed (745 resolved cases), compared with 30.2% across Art Unit 1634 over the last five years.

Does an interview help with examiner Stephen Thomas Kapushoc?

This examiner's interview lift is +53.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Stephen Thomas Kapushoc take to allow a patent?

Applications allowed by Stephen Thomas Kapushoc took 1,379 days on average from filing to allowance.

Which art unit does examiner Stephen Thomas Kapushoc work in?

Stephen Thomas Kapushoc examines applications in Art Unit 1634 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month